Ipca Laboratories Ltd.
BSE (Code: 524494) Prev. Close :938.20 Last updated : 20 Nov'09 15:56:00
Last Traded Change (%) Volume
940.15
1.95 (0.21) ▲
 2,307

P/E: 23.35 EPS: 40.25 Mkt. Cap: 2368 Cr.
Open: 952.90 Average Vol: 6,706
High: 952.90 52 Wk. High: 974.90
Low: 931.05 52 Wk. Low: 285.05

Install Adobe Flash Player to view BSE Chart

Install Adobe Flash Player to view BSE Chart

Install Adobe Flash Player to view BSE Chart
NSE (Code: IPCALABEQ) Prev. Close :942.85 Last updated : 20 Nov'09 15:40:13
Last Traded Change (%) Volume
944.10
1.25 (0.13) ▲
 4,031
Open: 940.00 Average Vol: 11,993
High: 955.00 52 Wk. High: 976.00
Low: 930.50 52 Wk. Low: 284.40
Company Information
Websitehttp://www.ipcalabs.com
IndustryPharmaceuticals
AddressRegistered Office : 48, Kandivli Industrial Estate, Kandivli (West), ,Mumbai, Maharashtra - 400067
ContactTel: 022-66474444, , , Fax: 022-28686613,
Face Value10
Bulk Deals
DateTypeCompanyQuantityPrice
23-Jul-08BuyPRUDENTIAL ICICI TRUST LTD AC DYNAMIC PLAN591000544
23-Jul-08SellHDFC STANDARD LIFE INSURANCE CO LTD590844544
10-Mar-08SellMORGAN STANLEY MAURITIUS CP LTD187998543
09-Jan-08SellMORGAN STANLEY MAU CO LTD157000705
08-Jan-08BuyHDFC MUTUAL FUND200000700
more >>
Ipca Labs a performer; target of Rs 1013: ICICIDirect.com
Moneycontrol.com  -  Thu, 29 Oct 2009 12:12
Ipca Labs Q2 net profit up at Rs 63.9 cr
Moneycontrol.com  -  Tue, 27 Oct 2009 13:04
Recors date for Ipca Laboratories interim dividend announced
NDTV Profit  -  Sun, 11 Oct 2009 18:30
IDBI Bank, IPCA Lab outperformers for Sep`09: Sharekhan
Myiris.com  -  Mon, 05 Oct 2009 10:38
Ipca Laboratories assigns credit rating
NDTV Profit  -  Sun, 13 Sep 2009 18:30
more >>
Sharekhan keeps BUY on Ipca Labs
livemint.com  -  Tue, 02 Jun 2009 10:13
Stock Update: Ipca Laboratories
livemint.com  -  Thu, 23 Apr 2009 09:59
more >>
Advertisements
Related Companies
CompaniesPriceMarket CapPE
Jubilant Organosys
Compare		305.45 (9.44)4507 Cr.17.28
Bliss GVS Pharma
Compare		29.45 (9.07)304 Cr.8.11
Natco Pharma Lim
Compare		114.20 (4.48)321 Cr.7.52
Fulford (India)
Compare		718.55 (3.33)280 Cr.14.21
Glenmark Pharma
Compare		254.10 (2.94)6850 Cr.31.43
Financial Results As of Jun - 09
Operating Income358.94
Operating Profit71.86
Reported PAT49.77
Operating Margin (%)20.02
Net Margin (%)13.71
Income Stmt Balance Sheet Cash Flow Ratios Quarterly
Share Holding
As of : June 30,2009
Share Holder No Of Shares % Holding
Promoters 1.16 Cr. 46.40
Foreign Institutions 1.95 Lakhs. 0.78
Non-Banking Mutual Funds 89.07 Lakhs. 35.68
General Public 28.66 Lakhs. 11.48
Financial Institutions 600 0.00
Others 2.19 Lakhs. 0.88
more >>